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Normal huntan melanocytes are often grown in vitvo 
' in the continuous presence of12-0-tetradecanoylphor-
bol-13-acetate (TPA) for growth in tlitvo. The expres-
sion of protein kinase C (PKC) subspecies, which are 
the major cellular receptors for phorbol esters, was 
examined in melanocytes after long-term treatntent 
with TPA to investigate the role ofPKC subspecies in 
, TP A-dependent cell growth. The PKC enzyme activ-
ity detected in quiescent 1nelanocytes was almost 
completely depleted in cells after incubation with 85 
nM TPA for 48 h. Immunoblot analysis indicated 
that, among the PKC subspecies a, {3, D, E, and ~ 
. expressed in quiescent cells, a-, {3-, 8-, and E-PKC 
were significantly down-regulated, whereas ~-PKC 
1 remained at detectable levels in TP A-treated cells. 
TP A did not significantly affect the expression or 
E isin gcr and Marko [ J] first reported in 1982 that norm al human. m.clanocytes requ.ire .thc co.ntinuou s presence of the phorbo l este r, 12-0-tctradecanoylphorbol-13-ace-tate (TPA), for their pro li feration i11 l'itro. It is generally accepted that the major intracellular receptor for TPA 
is protein kinase C (PKC) L2], a mu ltifunctiona l se rine/threonine 
protein kinase that plays crucial rol es in signal transduction [3,4]. 
PKC is activated by increased amounts of membrane d iacylglycer-
ols that resu lt fi·om agonist-induced hydrol ys is of inositol phospho-
lipids. TPA activates PKC direc tly in a manner ana logous to that of 
diacylgl yce rol both in cells and in a ce ll-fi·ee system. In a va riety of 
tissues and cell types, TPA indu ces persistent activation of PKC and 
then e licits depletion ofPKC or "down-regulation" [2]. Molecular 
clonin g and biochemical ana lysis have revealed the existence of 
multiple subspecies ofPKC, and more than ten subspecies ofPKC, 
including a, {31, {311, y, o, E, 'Y). 8, ~. and .\, have been identified in 
mammalian tissues r4J. Some m embers of the PKC fiunily exhibit 
differential enzyma tic properties and distinct pattems of tissue 
expression and intraceUular loca lization, and thus each member of 
the family is suggested to play a discrete ro le in the processing and 
mod ulation of a val"iety of physiol ogic and pathologic responses to 
extem al signals [3 ,4]. 
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subcellular distribution of ~-PKC in melanocytes. 
lntmunoprecipitation assay revealed that the enzyme 
activity of ~-PKC was increased in both the cytosol 
and particulate cell fractions, but the increase was 
much greater in the latter. The activation of ~-PKC 
lasted for 24 to 48 h after the addition of TPA; 
thereafter, ~-PKC activity returned to basal levels. 
DNA synthesis was shown to change concontitantly 
with the activation of ~-PKC in TPA-treated cells. 
These results indicate that TPA induces not only the 
down-regulation of a-, {3-, 8-, and E-PKC, but also 
long-term activation of ~-PKC in Inelanocytes, and 
that activation of ~-PKC parallels the growth of 
normal human ntelanocytes. Key wot'ds: TPA/mitogeu-
esis. J ltwest Der·matol 105:567-571, 1995 
Since the demonstration that normal human mclanocytes require 
the continuous presence of TPA for growth, much attention ha s 
been focused on the mechanism of the proliferation of m elanocytes 
induced by TPA [5,6). The long-term action ofTPA is thought to 
be important for the growth of m elanocytes, as membrane-per-
m eant diacylglyccrols, whjch arc transient activators of PKC, arc 
unable to stimulate the growth of these cells rsJ. Membrane-
permeant diacylglyce ro ls a rc known simpl y to activate PKC, but do 
not induce PKC down-regulation. Thus, it has been postulated that 
TPA-dependent growth of m elanocytcs is a consequence of the 
down-regulation of PKC indu ced by tumor-promoting phorbol 
esters [5] . Overexpression of a -PKC is associated with reduced 
growth and increased expression of differentiation markers in 
melanoma cells [7]. Therefore, PKC ha s been proposed to inhibit 
the proliferation of these cells . The present study was condu cted to 
investigate the long-te rm effects of TPA on each PKC subspecies. 
T PA treatment caused down-regulation of PKC subspecies a, {3, 8. 
and E but did not affect the expression of ~-PKC in melanocytes. 
Furthermore, TPA induced long-term activation of f:-PKC in 
me lanocytes. These resu lts suggest that PKC subspecies such as a, 
{3, 8, and E may be involved in the inhibi tion of the mjtogenic 
response and that TPA-activated ~-PKC might pla y a role in the 
growth regulation of no rmal human melmwcytes . 
MATER.IALS AND METHODS 
Cell Culture Normal human mclanocytcs were isolated fi·om inf.1n ti lc 
foreskins as described [8]. Melanocytcs were maintained in Ham's F-10 
n1 cd iun1 (An1crican IJiorganics, Inc., Ton:n and a, NY) containing I WX~ feta l 
bovine serum (GITICO Laboratories, Grand Island, NY), 200 U/ ml pcni-
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cillin. 100 J.Lg/ml streptom ycin . 85 nM T PA (Sigma C hemical Co .. St. 
Louis. MO). and 0 .1 mM isobutylmeth ylxa nthinc (S igma) (standard growth 
n1cdiun1). 
Preparation of Total PKC Extract and Cytosol and Particulate 
Fractions Melanocytes were cultured in standard growth medium with-
out T I'A for 72 h to render the ce ll s qui escent. Cell s were then treated with 
85 nM TPA for 48 h o r fo r the indi cated time periods. Quiescent and 
TPA-treated melanocytcs (3-5 X 107 ce ll s) were washed with phosphate-
bufl:c red saline and harvestcd by sc raping in phosphate-buffe red sa line. Cell s 
were then suspended in 4 vo lumes of buffer A: 20 mM Tris/1-ICI (pl-1 8 .0) 
conta ining 10 mM cthylcneglyco l-bi s(f3-aminocthyl ether)- N .N.N' ,N'-
tetraacctic acid (ECTA), 2 mM ethylencdiaminetetrnacetic acid (EDTA). 10 
mM 2-mercaptocthanol. 100 J.Lg/ml lcupeptin , 50 J.LM (p-amidinophenyl) 
methancsulfonyl fluoride hydrochlo rid e (p-APMSF). and 0.5%. (v/v) T riton 
X -1 00. Cells were then lysed by sonication using five 5- second bursts by a 
sonifier (Ultrasonic Processor Model VCSO with 2-mm probe; Sonics & 
Materials. Inc., Danbury, CT) and centrifuged at 100,000 X g fo r 60 min. 
T he supernatan t was used as the total PKC extract. For subcellular 
fractionation of melanocytcs, cells were suspended in 4 volumes o f buffer A 
w itho ut Triton X -1 00, lysed by sonication as described above , and centri-
fu ged at 100,000 X g for 60 min. The resulting ·upernatant was used as the 
cytoso l fraction. The pellet was lysed by sonica tion in buffer A and 
centrifuged at 100,000 X g fo r 60 min , and the supernatant was used as the 
particulate fraction . 
Mono-Q Column Chromatography Eq ual amo unts of pro tein (17 m g) 
of the total PKC extracts of quiescent and TPA-trcatcd m elanocytes were 
applied separately to a Mono-Q 1-IR 10/ 1 0 co lumn (I X 10 em ; Phannacia , 
Pi sca taway, NJ) connected to a fa st-protein liquid ch.romatograph y system 
(Pharmacia) and equi librated befo rehand with buffe r ll: 20 mM Tris/ 1-ICI 
(pl-1 8.0) containing 0.5 mM EGTA, 0.5 mM EDTA , 20 mM 2-mercapto-
ethano l, 20 J.Lgl ml le upeptin , 50 J.LM p-APMSF, 10% (v/v) glycerol, and 
0.02°/., (v/v) T riton X-100. Afrer washing the column w ith 10 ml of buffer 
B. we eluted PKC by ap plica tion of a 50-mllinea r concentration g radient of 
NaCl (0-0.5 M) in buffer l3 at a flow rate ofO.S mllmin. Fractions ofl ml 
each were coll ected. PKC activity was assayed by m easuring the incorpo-
rati on of32P fro m [ y- -' 2P]ATP into m yel.in basic protein (MBP) essentially as 
described [9 , 1 OJ. The reaction mixture (50 J.L I) contained 20 mM T1is/H C l 
(pH 7.5). lO mM MgC12 , 10 J.LM [1'-32P]ATP, 200 J.Lg / ml MBP, 16 J.Lgl ml 
phospha tidylsc rine, 1.6 J.Lgl ml diolein, 10 /.LM CaC12 , and 5 1-J.l of enzyme . 
Basal activity was m easured in the presence of 0.5 mM EGTA instead of 
phosphatidylserine , diolein , and C aC12 . After incubation for 15 mi n at 30"C, 
the reaction was terminated by spotting a 40-J.Ll aliquot of the reaction 
mixture onto P81 paper (Whatman , C li fton, NJ) . The paper was washed 
five times for 5 min each by immersion in 75 mM H 3P04 • Radioactivity was 
quantitated by C herenkov counting using a scintill ation liquid spectrom eter. 
lmmunoblot Analysis Immunoblot analysi s was carried out after partial 
purifi cation of PKC by diethylaminoethyl (DEAE)-cellulose co lumn ch.ro-
matography to reduce nonspecific binding . Total PKC extracts and cytosol 
and particulate fractions of quiescent and TPA-treated m elanocytes w ere 
applied separately to a DEAE-cellulose (DE-52; Wh atman) co lumn (0.5 X 
1 em), which was equilibrated beforehand w ith buffer C : 20 mM Tris/ 1-ICI 
(pl-1 8.0) containing 0.5 mM EGTA , 0.5 mM EDTA, and 10 mM 2-mer-
captoethanol. After tbe column was washed w ith bufrer C containing 20 
mM NaCI , PKC was eluted with 0.7 ml of buffer C containing 400 mM 
NaCI. Eq ual amounts o f protein (33 J.Lg/ lane) eluted from the DEAE-
cellulose column were subjected to sodium dodecylsulfatc-polyacrylamide 
ge l e lectrophoresis (SDS-PAGE) using a 7.5% ge l and transferred to an 
lm rnob il on membrane (Millipore Corp. , Bedford , MA) . The membrane 
was incubated ove.-ni [;h t at room temperature with Tris/NaC I bufrer (1 () 
mM T ri s/ HCI, pH 7.5, ;md 150 mM NaC I) conta ining 3'1., gelaLin and 
0.02% NaN3 , and then allowed to react with po lycl onal. antibody specifi c for 
a-, {3-. 5-, E-, and ~-PKC (C KpVS a -a. C KpV1 f3-a. C KpV30-a. CKpVSE-a, 
and CKpVS~-a. respectively ['I 'll) for I h at room temperature. After washing 
with Tris/NaCI buffCr containin g O.OStX• Tween 20, tl1 c membranes were 
incubated for 30 rnin at room tcmperatur<! w ith the biotin ylated anti-rabbit I[;G 
antibody. and subsequently with th<! avidin-bio t1n )da wd horseradish peroxidase 
complex (Vcctastain Eli te; Vector Laboratories, Burlingame, C A). The colo r 
r<!action was developed using diaminobenzidinc tctrah ydrochloridc and 1-120 2 . 
The a-, /3-, 0- , and E-PKC purifi ed from ra t br"i" j9.10."12] and the recombi-
nant ~- l'I<C ovc rexprcsscd in Chinese hamster ovary ccl.ls [1 3 J were used as 
:1 Utl1cntic CllZytnc smnplcs. 
Itnmunoprecipitation of ~-PKC Q ui escent and TPA-treawd mclano-
cytcs were washed three ti mes with icc-cold phosph ate-buffered saline and 
scraped in to bufl'e r D: 50 mM Tris/1-lC I (pl-1 7 .5) , 150 rnM NaCI, 5 mM 
ECTA , 15 mM /3-glycerophosphate, 1 mM Na.l YO.,, I mM dithiothreito l, 















Figure 1. TPA induces depletion of PKC activity. The total PKC 
extracts of quiescent (A) and TPA-treatcd (B) melanocytes were subj ected 
separately to Mono-Q column chromatography, and PKC activity was 
assayed as described in Materials a11d Methods. Solid circles, in the presence of 
phosphatidylserinc, diolein , and CaCI2 ; ope11 circles, in the presence ofEGTA 
instead of phosphatidylserine, diolein , and C aC12 ; dashed li11e, NaCl concen-
tration. 
20 J.Lg/mlleupeptin , and 50 J.LM p-APMSF. Cells were sonicated using fi ve 
5- second bursts and centrifuged at 100,000 X g for 15 min . The supernatant 
was used as th e cytosol. Pelle ts were lysed in bufl:c r D containing 1% (v/v) 
Triton X -1 00, sonicated using eight 5-sccond bursts, and centrifuged at 
I 00.000 X g for 15 min. T he supernatant was used as the parti cul ate. Equal 
amounts of protein (0 .2 mg for the cytosol and 0.1 m g for the particulate) 
were immunoprccipitated with 4 J.Ll (for the cytoso l) and 2 J.Ll (for the 
parti cul at<!) o f a nti-~-PKC antibody (CKpV S~-a) fo r 16 h at 0 - 4"C. After 
addition of 20 J.Ll (for the C)' toso l) and 10 J.LI (for th e parti culate) of 
protein-A- coupled Scpharose (Phannacia), the mi xture was incubated for 
~·mo the r 1 h with shaking. The resul tin g inmtun c complex was centrifuged 
and washed twice with buffer D containing 0. 5% Triton X-1 00. ;md once 
with buffer E: 20 mM 1-IEPES (pl-1 7.5) containing O.J mM Na3 VO.,. 0.1 
mM di thiothreitol , 50 J.Lglmlleupcptin , and 50 J.LM p-APMSF. T lw immune 
complex was resuspended in 20 J.L I o f buf!e r E and used fo r kinase assay of 
~- I'KC . T h" aaivity of s-I'KC was assayed by addi ng ·1 0 J.L I of the enzyme 
prepara tion dcscrib<!d above to 15 p.l of tlw reaction mi xtu re containing 20 
mM HEPES (pl-1 7.5), 4 mM MgCI2 , 10 I.LM Jy-3 2 P'JATP. 200 J.Lg/ m l MBP. 
and 30 /J.g/ml phosphatidylse rin c. After incubation lo r 7 min at 30°C. the 
reaction was stopped by addition of SDS-PAC E sample buffer, and the 
samples w<!re boiled for 5 min. Tlwse samples were subj <!ct<!d to SDS-PAGE 
usin g a gradient (5 4% to 201.V.~) ge l. and the phosphorylatio n of M 13P was 
visuali zed by autoradiograp hy. Radioacti vity inco rporated into the Mlll' 
band was quantitated by measuring the intensity of pllotostimulatcd lu mi-
ncsccnc<! using a bioimaging anal yzer (13AS 2000; Fuj i Film. T ok)•O, Japan) . 
Thymidine Incorporation Assay Quiescent melanocytcs (5 X 105 cell 
in 1 ml of culture medium per well) W<!re stimulated with 85 nM TPA. For 
, 
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Figure 2. TPA induces difrerential down-regulation of PKC sub-
species. T he tota l PKC extracts of qui escent {ln11e 1) and TPA-treated {ln11e 
2) mclanocytes were app li ed on DEAE-cellulose column , and eluates were 
subjected to imm unoblot analysis using antibodies aga inst each PKC 
subspecies. as described in JHnrerinls all!! Methods. lrnmunoreactions of each 
PKC subspecies were confi rmed by authentic enzyme samples. 
me last 6 h of each incubatio n. the cell s were cul tured with ["'H) th ymidine 
(0 .5 !-LCi per well ). Acid-precipitable material s were co ll ected on a glass 
filter, and radioactivity was qua ntitated with a liquid scintillation spectrom-
eter. 
Protein Detcrn1ination Protein content was dctennincd by th e 1ncthod 
' of Bradford ["14]. 
RESULTS 
TPA-Treated Melanocytes Show Depletion ofl'KC Activity 
To exa mine the long- term effects of TPA on PKC activity, we 
assayed PKC activ ities fi·om quiescent and TPA-treated melano-
cytes after Mono-Q co lumn chromatography. D istinct PKC activity 
was detected in quiescent melanocytes (Fig l A). In contrast, PKC 
activity was markedly reduced in TPA- treated cells, with very low 
activity o bserved in ti:action numbers 29 - 45 (Fig lB). 
PKC Subspecies Are Differentially Down-Regulated in 
TPA-Treated Melanocytes lmmunoblot analysis using anti -
bodies specific for each PKC subspecies was performed to examine 
the depletion of each PKC subspecies (Fig 2). Types a - , {3- , 8-, e-, 




Figure 3. Subcellular distribution of ~-PKC. T he cytosol ond partic-
ulate fractio ns of quiescent (/n11r '/) and TPA-treatcd (ln11e 2) m clanocytcs 
were app lied on DEAE-ccllulose column , and cluotcs were subjected to 
immunoblot analysis using on antibod y aga inst s-PKC . OS described in 
M nterinls a11d 1\1/cr/wds. 
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F igure 4. T PA indu ces activation of ~-PKC. s-PKC in the cytoso l and 
particulate from quiescent and TPA-trcatcd mclanocytcs was immunoprc-
cipitated and assayed as described in Matl'ria ls a11d Alctht>ds. Phosphoryla tion 
of M.13P was visualized by autoradiography (top) and onalyzcd by a bioimaging 
analyzer (lmrt1!1 11) . PSL, photostimulated luminescence. 
of immuno reactive PKC prote ins in quiescen t and TPA-treatcd 
ce lls revea led a marked decrease in a -, {3-, 8-, and e-PKC levels in 
TPA-treated cell s. Both a - and {3-PKC were undetectable, and 8-
and e-PKC were reso lved only fa in tly in TPA- treated cell s. In con-
trast, ~-PKC was present at essentially the same levels in TPA-
treated cells and in quiescent cells. decreasing sl ightly after TPA 
treatment. T hus, a - , {3- , 8- , and e-PKC proteins, but not ~-PKC , 
are down-regulated in TPA- treated cells. Subsequem analys is of the 
subcellular localization of ~-PKC (Fig 3) revea led ~-PKC in both 
the cytosol and particulate fractions in quiescen t melanocytes, and 
the immunoreactions of ' - PKC in each fraction were not alte red by 
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Figure 5. Time course of ~-PKC activation by TPA treatment. 
Melanocytes were trcqtcd with TPA for the indicated time periods. t-P.KC 
i11 the cytosol (nJ>CII circles) and particulate (solid circles) was immunoprecipi-
tated and assayed as described in Jltln tcrinls allll Mctlwds. Phosphorylation of 
MBP was analyz~d by a bioimaging ana lyzer. Results arc representative of 
three independent experiments. PSL, photostimulatcd luminescence . 
T PA treatment. T hese results indicate that TPA does not induce 
translocation or down-regulation of ~-PKC. 
~-PKC Is Activated in TPA-Treated Melanocytcs T he en-
zyme activity of ~-PKC was assayed afte r immunoprecipitation to 
remove other prote in kinases. lmmunoprecipi tated ~-PKC was 
quantitated by phosphorylation of MBP i.n tl11:: presence of phos-
phatidylserine without Ca + + (Fig 4), beca use ~-PKC is active 
under these conditions [15-18]. TPA treatment induced activation 
of ~-PKC in both the cytosol and particulate. ~-PKC activity 
increased slightly in the cytosol and approximately 2.4-fold in the 
particulate. T ime-course analysis indicated that ~-PKC activity in 
the particulate was highest 24 h afte r TPA treatment among the 
time points examin ed and returned to basa l levels at 72 h, whereas 
~-PKC activity in the cytosol increased slightly during the time 
course (Fig 5). 
~-PKC Activity Correlates with DNA Synthesis in Melano-
cytes To examine the relation be tween ~-PKC activity and DNA 
synthes is of me lanocytes, we performed a thymidine incorporation 
assay (Fig 6) . DNA synthesis was highest 24 h after the addition of 
TPA and decreased to basal levels in a pattern that para lleled the 
change in ~-PKC activity. Thus, ~-PKC activity , especially in the 
particul ate fraction, changes concomi tantly with DNA synthesis of 
melanocytes. 
DISCUSSION 
Normal human m elanocytes are known to express several PKC 
subspecies. T he a-, {3-, and E-PKCs have been detected by 
immunoblot analysis [6], and the presence of a-, {3-, 8-, and ~-PKC 
transcripts has been demonstrated by reverse transcriptase-poly-
merase chain reaction [19]. All of these PKC subspecies were 
detected by immunoblot analysis in this study. After TPA treat-
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Figure 6. Time course of the effect of TPA on DNA synthesis. 
Quiescent melanocytcs were stimulated with T PA for the indicated time 
periods, and incorporation of [3 H]thymidinc into cells was measured as 
described in Mnlc>ials nud Methods. Dat.1 points represent the mean ::':: SO of 
triplicate cultures. 
ment, a - , {3-, 0-, and E-PKC are down-regulated , whereas ~-PKC 
is repo rtedly neither translocated nor down-regulated in response 
to acute or chronic exposure to TPA [17,1 8,20 - 23]. ln the present 
study, we found that a - , {3-, 0-, and E-PKC expression in melano-
cytes is down-regulated as in other cells . In light of the proposal 
that TPA-dependent growth of melanocytes is a consequence of the 
down-regulation of PKC [5] , it seems possible that some PKC 
subspecies, especially a- and {3-PKC, which are deple ted com-
pletely by TPA treatment, may be responsible for inhibition of tl~e 
mitogenic response in m elanocytes. 
Our results also indicate that the expression and distribution of 
~-PKC are not affected by long-term treatment with TPA in 
melanocytes. Because ~-PKC has been suggested to play a crucial 
role in mitogenesis [24,25] and ~-PKC is expressed exclusively in 
m elanocytes growing i11 11itro, a role for ~-PKC in m elanocyte 
proliferation is possible. Previous studies have demonstrated the 
insensitivity of ~-PKC to TPA in a cell-free system [15-1 8]. We 
therefore focused on the effect of TPA on ~-PKC activity in 
m elanocytes. TPA induced long-term activation of ~-PKC in these 
cells, although the mechanism of induction remains unclear. One 
possibility is that the activity of ' -PKC is regulated through 
phosphorylation , analogous to the reported phosphorylation of a-
and 13-PKC on tyrosine residues (26-29] and the control of their 
activity through phosphorylation [26-30]. Some PKC subspecies 
activated by TPA might phosphorylate '-PKC, resulting in the 
modulation of its activity. It is also possible that the activity of 
~-PKC is controlled by some binding proteins to ~-PKC. Several 
proteins such as the receptors for activated C -kinases (31], Bruton 
\)'rosine kinase [32], and RAC protein kinase [33] have been shown 
to bind to PKC. These binding proteins might be phosphorylated 
by TPA-activated PKC, and the phosphorylated binding proteins 
m ay act to modulate ~-PKC activity. Further studies are required to 
elucidate the detailed biochemica l mechanism of ~-PKC activation 
in melanocytes. 
VOL. 105, NO. 4 OCTOBER 1995 
The skillful sccrctnrinl nssistnuce of S. f\ lishi)'nllln is acl.:m"''ll'dged. This tllork tl'as 
s 11ppo11ctl i11 pm1 l1y grn 111s .{ro111 the MilliSIIJ' of E d11cnrio11 , Scic11ce n11d C 11it11rc, 
]apa11. 
REFEREN CES 
1. Eisinger M, Marko 0: Selective proliferation of no rmal hurnnn mcltmocytes iu 
11itro in th e presence o f pho rbol es ter ~md cholera toxin. Pml" N at/ A cad Sri USA 
79:20 I H-2022, 1982 
2. N ishiz ukn Y: T he t:unil y of protein kinase C fo r signal transduction. )A1\1A 
262: 1826-1833' 1 98~ 
3. Nishizuka Y: T he mo lct..: ular heterogeneity of prot ein kin 11sc C and irs impli ca-
tio ns fo r cellular regula tion . N ature (Lo 11d) 334 :661-665. 1988 
4. N ishizuka Y: lntracc ll u l :~r signaling: by hydro lys is of phospholipids and activilrion 
of prote in kinase C. Sc:it·ucc 258:607- 6 14, 1992 
5. Brooks G, Wi lson KE, Dooley TP, Goss MW. 1-lil r t IR: Protc iu kinase C 
down-regulation. and no t. transient activ:ltion , correlates with me lanocyte 
growth. Ctmw· Res 5 1:328 1-3288, 199 1 
6 . Arita Y. O' Driscoll Kit. \Veinstein 113 : Growth of hmnnn melauocytc cultures 
supported by 12-0-tctradccanoylphorbol- 13-accra l-c is mediated through pro-
tein kinnsc C activation . Cmtrer Rrs 52: 45 14-·152 1. 1992 
7. Grubcrs JR., O hno S. N ile lt.M: l n c rc :~ scd expression o f protein kinase Ca plays 
a key ro le in retin o ic acid-induced melanoma di tTercntiariotJ. J Bioi C ltem 
267: 13356- 13360, 1992 
8 . Horikawa T, N ishi no K, M.isltima Y : Melan ocy te gro wth tUctor in normal human 
skin . P(~III C II t Cell Res.4: 48-5 1, 199 1 
9. Ogi ta K. Mi yam oto S. Y:unagudti K, Koide H . Fujisawa N , IGkkawn U, Sa hara 
S. Fukam_i Y. N ishizuk a Y: Isohuion and charac tc ri z~Jtion o f 5-subspecics of 
protein kinnse C from rat brnin. Proc Nat/ Acatl Sci USA 89: 1592-1 596 , 1992 
10. Koidc H . Ogira K. Kikk:n va U, N ishizuka Y: lso l:ttion :m el characteriz:aion ofrhc 
E subspecies of pro tein kinase C from rnr brain . Pmr Nn tl ! lend Sci USA 
89: 11 49- 11 53, 1992 
11 . Fujisaw:1 N, Ogita K, Saito N. Nishizuka Y: Ex pression o f protein kinase C 
subspecies in rnt retina. FEUS Lclf 309:409-4 12, 1992 
12. Kikknwa U, O no Y , Ogim K, Fujii T , Asaoka Y, Sekiguchi K. l<osakn Y, Igara shi 
K. Nishizuka Y: Identification of the structures of multiple subspecies of 
protein kitwse C expressed in rat brain . FEB · Lt:lt 2 17:227-23 1, 1987 
13 . Watanabe T, O no Y, Ta ni yam a Y, Hazama K. Jgar:tshi K. Ogita K. Kikkawa U. 
Nishizuka Y: Cell division arres t induced by phorbol ester in C F-1 0 ce lls 
overexprcssiug: pro rcin kinilse C-5 subspecies. Pm,; Nn tl Art~d Sri USA 89: 
10 "1 59-10 163, 1992 
14. Bradford MM: A ra pid nnd sensitive method fo r the q uantiration of microgram 
CJU antities o f protein utiliz ing the principle of pro tein-dye binding. A 11nl 
lJiocilcm 72:248-254, 1976 
15. O no Y. Fujii T, Ogira K, Kikkaw:1 U , Ign rashi J<, Nish.izuka Y: Pro te in kinase C 
{subspecies from rat brain: its structure, expression . and properties. Proc Nntl 
Acml Sri USA 86:3099 - 3 103. 1989 
16. Nakanishi H. Exton JF-1 : Purifi cation and chnra ctcriz:ttion of rit e { isoform of 
pro rci n kinase C fro m bovine kidney . J IJir,f C lt cm 267: 16347-16354. 1992 
ACTIVAT ION O F l'KC IN HUMAN M ELANOCYTES 571 
17. Ways OK, Cook PP. Webster C . Pnrkcr PJ: Effect o f phorbol es ters on pro tein 
kinnse C - . ) Bioi C llcm 267:4799-4805 . 1992 
18. Koclts G . Humme l R . Meyer 0, l-lug 1-J . MnrmC D. Sarrc TF: Activarion and 
substr;Hc specificity of the hum au protein kinase C 0' and ( isocnzymcs. Eur_l 
Biorll cm 2 16:597-606, l 993 
19. Fisher GL, Tnvakkol A, Lench I< , Burns D, Unstn 1'. Loomis C, Grifliths CEM, 
Cooper l<D, R eynolds N.J. Elder JT. Livnch E. Voorhees JJ: DiffcrcnLial 
expression of protein k.i nn sc C isoenzym cs in norm:tl and psorintic 3dulr hum an 
skin: red uced expression ofpro te i_n kin~t sc C-{:UI in psoria sis. ) iii i'CSI Dcm w tol 
·1 0 I :553- 559, 1993 
20. O liver AR, P:1rkcr PJ : Identifi cation o f multiple PKC isofOnns in Swi ss 3T3 celk 
differcntin l down-regul ation by phorbol ester. ) Cell Pilysiol 152:240-244 , 1992 
2 1. Gschwc1Jdt. M, Lcibersperg:cr H . Kit tstci n \\I, Marks F: Pro tein ki ll :ISC C{ nnd '1 
in muri ne epidermis. TPA ind uces down- regul:lcion of PKC')1 bur no t PKC{. 
FE JJS Lt'lf 307: 15 1- 155, 1992 
22. Liyana ge M , Frith D. Livneh E. Sta ht! l S: Protein kinase C group B mem bers 
PKC-Ii, -€, -~ an d PKC-L(lJ). /Ji<>clw11 ) 283:78 1-787. 1992 
23. C hen CC: Protein kinase C a. 0, E nnd ( in Cf, g liom a cells. TPA ind uces 
tr:-mslo cati on and down-J·cgulaLion or conventional and new PKC isoforms bu r 
no t ntypica l PKC~. FEBS Leu 332: 169- 173. 1993 
2·L Dom inguez I. Diaz-Mcco MT, Muni cio MM . Berra E, Garcia de H erreros A. 
Corne t M_E, Sa nz L. Moscar J: Evidcnt:c tOr a ro le of pro rei n kinase C { 
subspecies in nwturntion of Xenopus lacvis oocytes. Mal Cell Bioi 12:3 77(,-
3783, 1992 
25 . Ucrr:l E. D iaz-Meco MT, Do rn ingucz I. Munid o MM . Sanz L. Lozano J. 
C hapkin RS. Mosc:1t J: Pro tein kinase C { isof(lrm is critical for m irogcnic 
signal tra nsductiou. Cell 74:555-563 , '1993 
26. Denning MF. Dlugosz AA. Howerr MK . Yuspa SH : Ex pression of an onco~cnic 
rns 1 1" gene in murine kcrntinocyrcs induces ryros inc phosphorylation nnd 
reduced activity of protein kinase C 5. ) Bioi CI1C111 268:20079-2608 1, 1993 
27. Li W, Misch:tk H. YuJ- . Wang L-M. M11shin skij F. Heidaran MA , Picrcc jf-1 : 
T yrosine phosphorylation of pr01·ein kinase C-S in response ro its activation . .J 
Bi<>l CIICIII 269:2349-2352, 1994 
28. Gschwcndt M. Kie lbassa K. K.instcin W . Marks F: Ty1·osinc phosphorylation and 
stimulation of protein kin:tsc CS from porcine spleen by src in vitro: depen-
de nce on the activnted stnl.e of protein kinase Cll. FEJJS L<fl 347:85-89, 1994 
29 . Liu F. n ... o tb RA: lnsul in-s6mulatcd tyros in e phosphorylati on of prurcin kinase 
Ca: evidence fi.)r direct interaction of the insulin rccepror and protein kinase C 
in cells. Bioclll'lll BioJ'It p Rl's Cou/1111111200:1570-1577. 1994 
30. Pears C. Stabcl S. Cilzowbon S. Pa rker PJ : Studies on the phosphorylati on of 
prote in kin ase C - 0' . Biodtt'llt J 283:5 15- 5 18. 19')2 
3 1. R on D. C hen C-1-1, C:J ldwcll J , Jamieson L, O rr E, Mochl y-R osen D: C loning 
o f :111 intracellular receptor for protein kiuasc C: a ho mo log of the f3 subuni r of 
G prote ins. Pmc at/ Acatl Sri USII 91:839-843, 1994 
32. Yao L. Kawakami Y. Kawakami T: T he plccksll·in ltomology do main of llruHHl 
tyros in e kinase interac ts with pro rcin kinase C. Pror Nat/ Acad Sci US I-1 
9 1 :9 175- 9 179 , 1994 
33. Konishi H. Kuroda S. Kikkawa U: T he pleckstrin homology domain of rt.A C 
pro te in kinase associa tes with the reg-u lnlo ry domnin o f pro tein kinase C {. 
Biodtcm Uioplt)1S Res Comm1111 205: 1770- 1775, 1994 
